Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Management of Irregular Density with Central Lucency or Cavitation

Initial Diagnostic Approach

  • The American College of Radiology recommends CT imaging with thin sections to fully characterize the lesion's size, margins, internal architecture, and relationship to surrounding structures 1
  • Lesions with irregular borders suggest higher malignant potential, according to the Radiological Society of North America 2, 3
  • The presence and pattern of central lucency or cavitation affects differential diagnosis and management, as stated by the American Thoracic Society 1

Tissue Diagnosis Strategy

  • The National Comprehensive Cancer Network recommends core needle biopsy (CNB) as the preferred initial approach for tissue diagnosis, as it provides sufficient tissue for histologic diagnosis and eliminates the need for confirmatory biopsy in most cases 4
  • CNB should be performed under image guidance, and multiple cores (3-5) should be obtained to ensure adequate sampling, according to the National Comprehensive Cancer Network 4
  • A radiopaque marker/clip should be placed at the biopsy site to facilitate localization if the lesion is small or may be completely removed during sampling, as recommended by the National Comprehensive Cancer Network 4

Surgical Approach When Excision is Required

  • The American Cancer Society recommends image-guided localization for non-palpable lesions, and the incision should be placed as close to the lesion as possible to avoid tunneling and achieve optimal cosmesis 7
  • The specimen should be removed in one piece, rather than multiple fragments, to allow proper margin assessment and size determination, according to the American Cancer Society 7
  • Surgical clips should be placed to mark the excision cavity for radiation planning if needed and to facilitate future imaging, as recommended by the American Cancer Society 7

Management Based on Final Pathology

  • If malignancy is confirmed, proceed according to disease-specific guidelines for definitive treatment, as stated by the National Comprehensive Cancer Network 4
  • Re-excision is recommended for atypical hyperplasia, lobular carcinoma in situ (LCIS), or other high-risk lesions due to underestimation rates of 20-30% for concurrent malignancy, according to the National Comprehensive Cancer Network 4
  • Close surveillance with serial imaging may be appropriate in select cases after multidisciplinary discussion, as recommended by the National Comprehensive Cancer Network 4